AbbVie (ABBV) Other Non Operating Income (2012 - 2026)

AbbVie (ABBV) has reported Other Non Operating Income for 15 consecutive years, with -$2.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income fell 59.58% year-over-year to -$2.3 billion; the TTM figure through Mar 2026 stood at -$6.2 billion (down 120.06% YoY), while the FY2025 annual figure was -$5.8 billion, down 27485.71% from the prior year.
• Other Non Operating Income declined to -$2.3 billion in Q1 2026 per ABBV's latest filing, from -$1.2 billion in the prior quarter.
• Across five years, Other Non Operating Income topped out at $776.0 million in Q1 2022 and bottomed at -$2.6 billion in Q2 2025.
• Historically, Other Non Operating Income has averaged -$918.1 million across 5 years, with a median of -$1.2 billion in 2025.
• On a YoY basis, Other Non Operating Income climbed as much as 8722.22% in 2022 and fell as far as 14525.0% in 2022.
• AbbVie's Other Non Operating Income stood at -$2.3 billion in 2022, then soared by 33.5% to -$1.6 billion in 2023, then surged by 98.78% to -$19.0 million in 2024, then tumbled by 6268.42% to -$1.2 billion in 2025, then slumped by 90.58% to -$2.3 billion in 2026.
• Business Quant data shows ABBV's Other Non Operating Income at -$2.3 billion in Q1 2026, -$1.2 billion in Q4 2025, and -$20.0 million in Q3 2025.